Burned for the last time. The FDA delays US market to Insmed for close to 3 years.
Insmed just got really bad news from the FDA. It will be almost 3 years before Arikayce gets into the US market
and that is if everything goes smothly.I expect the EMA to wait for the global Phase 3 trials results and they will be late 2018. We have to admit Insmed is a high risk stock to own for a long time.